Oxford halts trial of AstraZeneca COVID vaccine in children and teenagers over blood-clotting issue – MarketWatch
The University of Oxford has paused administering doses of the COVID-19 vaccine it developed with AstraZeneca PLC AZN, -0.63% AZN, +0.15% in a small …